Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, blocks neuroinflammatory signalling by targeting the transactivator of transcription (Tat) protein.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples